Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 660 of 1,261
  1. US 9512406

    Generating hepatocytes

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  2. US 9512133

    NMDA receptor modulators and uses thereof

    Northwestern University · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  3. US 9512138

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  4. US 9512118

    Crystal of fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  5. US 9512114

    Substituted aminopyrimidine compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  6. US 9512107

    Therapeutically active compositions and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  7. US 9511212

    Implantable drug delivery device

    Nano Precision Medical, Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  8. US 9511175

    Medical devices with an activated coating

    Covidien LP · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  9. US 9511152

    Multicolored pH-activatable fluorescence nanoplatform

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  10. US 9512224

    Use of semaphorin-4D binding molecules for treatment of atherosclerosis

    VACCINEX, INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  11. US 9513289

    Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases

    The United Sates of America, as Represented by the Department of Veterans Affairs · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  12. US 9512135

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  13. US 9513287

    High affinity monoclonal antibodies for detection of shiga toxin 2

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  14. US 9512401

    B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  15. US 9512212

    Bispecific antibody fragments for neurological disease proteins and methods of use

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  16. US 9512204

    Humanized pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  17. US 9512191

    Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  18. US 9512180

    Compstatin analogs

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  19. US 9512143

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  20. US 9512125

    Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  21. US 9512065

    Polymorphs of N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide hydrochloride

    KalVista Pharmaceuticals Limited · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  22. US 9511140

    Stable VEGF antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  23. US 9511121

    Method for delivering exenatide to a patient in need thereof

    Rani Therapeutics, LLC · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  24. US 9511067

    Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.